Gabelli & Co Investment Advisers’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-71,496	Closed	-$15.5M	–	544
2021 Q1	$15.5M	Buy	+71,496	New	+$13.4M	1.93%	11

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Gabelli & Co Investment Advisers's GWPH Position: Q2 2021 in Review

Gabelli & Co Investment Advisers sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 71,496 shares — an estimated $15.5M sold.

Gabelli & Co Investment Advisers first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $15.5M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Gabelli & Co Investment Advisers reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 71,496 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $15.5M.
Gabelli & Co Investment Advisers first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Gabelli & Co Investment Advisers's GW Pharmaceuticals Plc American Depositary Shares position peaked at $15.5M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2021, filed 13 Aug 2021.